DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
61.1% Decrease Gene Expression Level |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
Molecular |
frontal lobe |
Human |
FCGRT |
89.3% Increase Gene Expression Level |
|
DAA2293 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
52.1% Increase Gene Expression Level |
|
DAA2292 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
frontal lobe |
Human |
FCGR2A |
104.3% Increase Gene Expression Level |
|
DAA2291 |
Fc fragment of IgG binding protein increases with age |
Molecular |
frontal lobe |
Human |
FCGBP |
212.4% Increase Gene Expression Level |
|
DAA2290 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
111.4% Increase Gene Expression Level |
|
DAA2289 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
105.3% Increase Gene Expression Level |
|
DAA2288 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
383.1% Increase Gene Expression Level |
|
DAA2287 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
283.0% Increase Gene Expression Level |
|
DAA2249 |
NLR family, pyrin domain containing 1 decreases with age |
Molecular |
frontal lobe |
Human |
NLRP1 |
29.4% Decrease Gene Expression Level |
|
DAA2248 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
frontal lobe |
Human |
CASP1 |
30.2% Increase Gene Expression Level |
|
DAA2247 |
pannexin 1 decreases with age |
Molecular |
frontal lobe |
Human |
PANX1 |
59.9% Decrease Gene Expression Level |
|
DAA2246 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
250.2% Increase Gene Expression Level |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
277.8% Increase Gene Expression Level |
|
DAA2244 |
S100 calcium binding protein A9 increases with age |
Molecular |
frontal lobe |
Human |
S100A9 |
92.8% Increase Gene Expression Level |
|
DAA2243 |
S100 calcium binding protein A8 increases with age |
Molecular |
frontal lobe |
Human |
S100A8 |
921.4% Increase Gene Expression Level |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
frontal lobe |
Human |
MYD88 |
58.7% Increase Gene Expression Level |
|
DAA2241 |
toll-like receptor 5 increases with age |
Molecular |
frontal lobe |
Human |
TLR5 |
48.7% Increase Gene Expression Level |
|
DAA2240 |
toll-like receptor 4 increases with age |
Molecular |
frontal lobe |
Human |
TLR4 |
83.7% Increase Gene Expression Level |
|
DAA2239 |
toll-like receptor 4 increases with age |
Molecular |
frontal lobe |
Human |
TLR4 |
150.9% Increase Gene Expression Level |
|
DAA2238 |
toll-like receptor 4 increases with age |
Molecular |
frontal lobe |
Human |
TLR4 |
148.4% Increase Gene Expression Level |
|
DAA2237 |
toll-like receptor 2 increases with age |
Molecular |
frontal lobe |
Human |
TLR2 |
155.6% Increase Gene Expression Level |
|
DAA2236 |
CD14 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD14 |
134.9% Increase Gene Expression Level |
|
DAA2235 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
36.3% Decrease Gene Expression Level |
|